Patents Assigned to Chiba-Perfecture
  • Nucleic acid sequences showing enhanced expression in benign neuroblastoma compared with acritical human neuroblastoma
    Patent number: 7087383
    Abstract: There are disclosed a nucleic acid which is derived from the gene expressed in human neuroblastoma, and which comprises any sequence selected from the group consisting of the nucleic acid sequences set forth SEQ ID NO:1 to NO:104 in the Sequence Listing, or its complementary nucleic acid; a fragment of the nucleic acid; their use as probes or primers; and the diagnosis of neuroblastoma prognosis using any of the foregoings.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: August 8, 2006
    Assignees: Hisamitsu Pharmaceutical Co., Inc., Chiba-Perfecture
    Inventor: Akira Nakagawara